Pages that link to "Q81493963"

The following pages link to Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth (Q81493963):

Displaying 44 items.

• Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics (Q27316086) (← links)
• Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death (Q28069852) (← links)
• Cellular functions of tissue transglutaminase (Q28260600) (← links)
• Dependence of invadopodia function on collagen fiber spacing and cross-linking: computational modeling and experimental evidence (Q30483094) (← links)
• A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis. (Q30547848) (← links)
• Transglutaminase regulation of cell function. (Q33707936) (← links)
• Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site (Q34142460) (← links)
• GPR56 Interacts with Extracellular Matrix and Regulates Cancer Progression (Q34187828) (← links)
• Fibroblast-endothelial partners for vascularization strategies in tissue engineering (Q35167289) (← links)
• Temporal genome expression profile analysis during t-cell-mediated colitis: identification of novel targets and pathways. (Q35551204) (← links)
• Transglutaminase 2 inhibitors and their therapeutic role in disease states (Q35989247) (← links)
• Tissue Transglutaminase Does Not Affect Fibrotic Matrix Stability or Regression of Liver Fibrosis in Mice (Q36028696) (← links)
• Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. (Q36276954) (← links)
• Roles of transglutaminases in cardiac and vascular diseases (Q36664166) (← links)
• Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation. (Q36703863) (← links)
• Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer (Q36879220) (← links)
• Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney. (Q36905578) (← links)
• Endothelial sirtuin 1 deficiency perpetrates nephrosclerosis through downregulation of matrix metalloproteinase-14: relevance to fibrosis of vascular senescence (Q37524071) (← links)
• Recent advances in the development of tissue transglutaminase (TG2) inhibitors (Q37967368) (← links)
• Physiopathological Roles of Human Transglutaminase 2 (Q37973368) (← links)
• The extracellular matrix modulates the hallmarks of cancer (Q38266276) (← links)
• Crystallization and preliminary X-ray crystallographic studies of transglutaminase 2 in complex with Ca2 . (Q38618937) (← links)
• Transglutaminase 2 in cancer (Q38648421) (← links)
• Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells (Q38715434) (← links)
• miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer (Q38879949) (← links)
• Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma (Q39180406) (← links)
• Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells (Q40760483) (← links)
• The transglutaminase 2 gene is aberrantly hypermethylated in glioma (Q41903416) (← links)
• GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2. (Q42004258) (← links)
• The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition (Q42261474) (← links)
• Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2. (Q47685543) (← links)
• Proteomic Profiling Reveals the Transglutaminase-2 Externalization Pathway in Kidneys after Unilateral Ureteric Obstruction. (Q48139494) (← links)
• Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation (Q49509910) (← links)
• Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis. (Q52585194) (← links)
• Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. (Q54969723) (← links)
• Are Transglutaminase 2 Inhibitors Able to Reduce Gliadin-Induced Toxicity Related to Celiac Disease? A Proof-of-Concept Study (Q57937529) (← links)
• A composite of urinary biomarkers for differentiating between tubulointerstitial inflammation and interstitial fibrosis/tubular atrophy in kidney allografts (Q60311100) (← links)
• The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression (Q64249805) (← links)
• Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis (Q83099536) (← links)
• RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies (Q83186425) (← links)
• Immunohistochemical characteristics of regenerated bone after surgical therapy of advanced ligature-induced peri-implantitis defects (Q86836745) (← links)
• The diamond anniversary of tissue transglutaminase: a protein of many talents (Q87593562) (← links)
• Structures of Human Transglutaminase 2: Finding Clues for Interference in Cross-linking Mediated Activity (Q90632694) (← links)
• Urinary transglutaminase 2 as a potent biomarker to predict interstitial fibrosis and tubular atrophy of kidney allograft during early posttransplant period in deceased donor kidney transplantation (Q91813442) (← links)